Extract

The purpose of this study is to determine whether the safety, tolerability and pharmacodynamics of SB656933 in patients that have cystic fibrosis

Inclusion criteria

• Cystic fibrosis

Country

• Canada
• France
• Germany
• Israel
• United States

Links

• gsk
• nct
• ictrp